You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

KCP-330

Showing 1 - 25 of 154
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Myeloma Trial in West Hollywood, Cary (Selinexor, Placebo (for selinexor), carfilzomib)

Withdrawn
  • Multiple Myeloma
  • West Hollywood, California
  • +1 more
Jan 24, 2023

Hematological Malignancies Trial in Canada, Denmark, United States (KPT-330)

Completed
Has Results
  • Hematological Malignancies
  • Tampa, Florida
  • +11 more
Mar 5, 2021

Non-Small Cell Lung Carcinoma (NSCLC), Colorectal Cancer (CRC), Other Solid Tumors Trial in Israel (Selinexor 100 mg, Docetaxel,

Recruiting
  • Non-Small Cell Lung Carcinoma (NSCLC)
  • +2 more
  • Selinexor 100 mg
  • +6 more
  • Ashdod, Israel
  • +10 more
Jan 30, 2023

Glioblastoma, Glioma Trial in Denmark, Netherlands, United States (Selinexor)

Terminated
Has Results
  • Glioblastoma
  • Glioma
  • Boston, Massachusetts
  • +5 more
Jan 24, 2023

Endometrial Cancer Trial in Worldwide (Selinexor, Matching for selinexor)

Active, not recruiting
  • Endometrial Cancer
  • Tucson, Arizona
  • +104 more
Aug 11, 2022

Prostate Cancer Trial in Houston (Selinexor)

Terminated
Has Results
  • Prostate Cancer
  • Houston, Texas
    M.D. Anderson Cancer Center
Jan 7, 2021

Acute Myeloid Leukemia (AML) Trial in Worldwide (Selinexor, Hydroxyurea, Ara-C)

Completed
Has Results
  • Acute Myeloid Leukemia (AML)
  • Los Angeles, California
  • +77 more
Jan 24, 2023

Relapsed/Refractory Diffuse Large B-cell Lymphoma Trial in Worldwide (Selinexor (combination therapy), Placebo matching for

Recruiting
  • Relapsed/Refractory Diffuse Large B-cell Lymphoma
  • Selinexor (combination therapy)
  • +7 more
  • Chandler, Arizona
  • +51 more
May 6, 2022

Corneal Thinning, Keratoconus Trial in Pittsburgh (Pulsed or continuous lighting)

Not yet recruiting
  • Corneal Thinning
  • Keratoconus
  • Pulsed or continuous lighting
  • Pittsburgh, Pennsylvania
    UPMC Eye Center
Aug 3, 2022

Advanced or Metastatic Solid Tumors, Non-Hodgkin Lymphoma Trial in San Antonio (WTX-330)

Recruiting
  • Advanced or Metastatic Solid Tumors
  • Non-Hodgkin Lymphoma
  • San Antonio, Texas
    NEXT Oncology
Jan 6, 2023

Relapsed/Refractory AML, Minimal Residual Disease Positive AML, Myelodysplastic Syndrome Trial in Worldwide (AMG 330)

Terminated
  • Relapsed/Refractory AML
  • +2 more
  • AMG 330
  • Birmingham, Alabama
  • +10 more
Nov 9, 2022

Coronavirus Infection Trial (Selinexor)

Withdrawn
  • Coronavirus Infection
  • (no location specified)
Jan 19, 2023

Atopic Dermatitis Trial in Canada, China (Core Treatment Active Experimental: SHR0302 Dose#1, Core Treatment Active

Recruiting
  • Atopic Dermatitis
  • Core Treatment Active Experimental: SHR0302 Dose#1
  • +4 more
  • Surrey, British Columbia, Canada
  • +43 more
Oct 31, 2022

Keratoconus, Pellucid Marginal Corneal Degeneration, Corneal Ectasia Trial in San Francisco (PXL-330 Platinum device for

Recruiting
  • Keratoconus
  • +2 more
  • PXL-330 Platinum device for crosslinking with Peschke riboflavin solution
  • San Francisco, California
    Goodman Eye Center
Aug 19, 2022

Keratitis, Corneal Ulcer Trial in United States (Standard of Care Therapy + CXL + Riboflavin 0.23% L Solution, Standard of Care

Recruiting
  • Keratitis
  • Corneal Ulcer
  • Standard of Care Therapy + CXL + Riboflavin 0.23% L Solution
  • Standard of Care Therapy + Sham CXL + Artificial Tears
  • Tampa, Florida
  • +7 more
Jul 13, 2022

Keratitis, Corneal Ulcer Trial in United States (PXL Platinum 330 system + Riboflavin 0.25% TE Solution, Sham CXL + Artificial

Recruiting
  • Keratitis
  • Corneal Ulcer
  • PXL Platinum 330 system + Riboflavin 0.25% TE Solution
  • Sham CXL + Artificial Tears
  • Tampa, Florida
  • +7 more
Jul 13, 2022

Keratoconus, Pellucid Marginal Corneal Degeneration, Corneal Degeneration Trial in Dallas (PXL-330 Platinum device for

Recruiting
  • Keratoconus
  • +3 more
  • PXL-330 Platinum device for crosslinking with Peschke riboflavin solution
  • Dallas, Texas
    Cornea Associates of Texas
Mar 7, 2022

Keratoconus, Cornea Ectasia Trial in Orland Park (Epithelial-on Corneal Crosslinking with the PXL 330 Platinum system.)

Recruiting
  • Keratoconus
  • Cornea Ectasia
  • Epithelial-on Corneal Crosslinking with the PXL 330 Platinum system.
  • Orland Park, Illinois
    Arbor Center for Eye Care
Mar 16, 2022

Alopecia Areata Trial in China (SHR0302, Placebo)

Recruiting
  • Alopecia Areata
  • Hefei, Anhui, China
  • +31 more
Jul 21, 2022

Pulmonary Embolism Trial in Lørenskog (Low iodine Spectral Detector CT Pulmonary Angiography)

Completed
  • Pulmonary Embolism
  • Low iodine Spectral Detector CT Pulmonary Angiography
  • Lørenskog, Viken, Norway
    Akershus University Hospital
Nov 24, 2022

Dedifferentiated Liposarcoma Trial in Worldwide (Selinexor, Placebo)

Completed
Has Results
  • Dedifferentiated Liposarcoma
  • Los Angeles, California
  • +70 more
Jan 5, 2023

Corneal Ectasia, Keratoconus, Pellucid Marginal Corneal Degeneration Trial in Littleton, Highland Park, Brecksville (PXL-330

Recruiting
  • Corneal Ectasia
  • +2 more
  • PXL-330 Platinum device for crosslinking with Peschke riboflavin solution
  • Littleton, Colorado
  • +2 more
Jan 24, 2022

Multiple Myeloma Trial in Worldwide (Selinexor, Dexamethasone)

Completed
Has Results
  • Multiple Myeloma
  • Birmingham, Alabama
  • +60 more
Jan 24, 2023

Ovarian Carcinoma, Endometrial Carcinoma, Cervical Carcinoma Trial in Belgium, Denmark (Selinexor)

Completed
Has Results
  • Ovarian Carcinoma
  • +2 more
  • Leuven, Belgium
  • +3 more
Jan 13, 2021

Multiple Myeloma in Relapse Trial in Aurora (Selinexor, Pomalidomide, Daratumumab)

Recruiting
  • Multiple Myeloma in Relapse
  • Aurora, Colorado
    University of Colorado Hospital
Jan 31, 2023